Back to Research Hub
Medpace Holdings, Inc.
MEDP
$466.79+8.89 (+1.94%)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
StreetsValue research for Medpace Holdings, Inc. (MEDP)
Members get the full report for Medpace Holdings, Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.